Sandostatin LAR Depot (octreotide acetate) Injectable Suspension
Drug company: Novartis
800-282-7630
Novartis Patient Assistance NOW Oncology provides 2 financial assistance programs for patients using Sandostatin LAR Depot:
Novartis Oncology Universal Co-pay Program
Novartis Patient Assistance Foundation
Somatuline Depot (lanreotide) Injection
Drug company: Ipsen
866-435-5677
Ipsen Cares offers 2 financial assistance programs for patients using Somatuline Depot:
Somatuline Depot Virtual Copay Savings Program
Somatuline Depot Patient Assistance Program
Xermelo (telotristat ethyl) Tablets
Drug company: TerSera Therapeutics
888-600-8116
TerSera Therapeutics offers 2 financial assistance programs for patients using Xermelo:
Xermelo Co-pay Program
TerSera Support Source
Table. Drugs Prescribed for Carcinoid Syndrome
- Drug name (generic name)
- Drug company
- Indications
- Patient support services
- Sandostatin LAR Depot (octreotide acetate) Injectable Suspension
- Novartis
- Treatment of severe diarrhea or flushing episodes associated with metastatic carcinoid tumors
- Novartis Oncology Universal Co-pay Program
877-577-7756
Novartis Patient Assistance Foundation
800-277-2254
Drug name (generic name)
Drug company
Indication
Patient support services
- Somatuline Depot (lanreotide) Injection
- Ipsen
- Treatment of adults with carcinoid syndrome tumors
- Somatuline Depot Virtual Copay Savings Program
866-435-5677
Somatuline Depot Patient Assistance Program
866-435-5677
Drug name (generic name)
Drug company
Indication
Patient support services
- Xermelo (telotristat ethyl) Tablets
- TerSera Therapeutics
- Treatment of carcinoid syndrome diarrhea, in combination with a somatostatin analog
- Xermelo Co-pay Program
888-600-8116
TerSera Support Source
844-937-6356
Drug name (generic name)
Drug company
Indication
Patient support services
